Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy

[1]  V. Lokeshwar,et al.  Targeting hyaluronic acid family for cancer chemoprevention and therapy. , 2014, Advances in cancer research.

[2]  Hao Cheng,et al.  Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. , 2016, Nano letters.

[3]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[4]  B. Sugarman,et al.  Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration , 2015, The AAPS Journal.

[5]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[6]  M. M. Hasani-Sadrabadi,et al.  Exosome-inspired targeting of cancer cells with enhanced affinity. , 2016, Journal of materials chemistry. B.

[7]  A. Prokop,et al.  Nanovehicular intracellular delivery systems. , 2008, Journal of pharmaceutical sciences.

[8]  M. Baker.  Making membrane proteins for structures: a trillion tiny tweaks , 2010, Nature Methods.

[9]  V. Kosma,et al.  Hyaluronan in human malignancies. , 2011, Experimental cell research.

[10]  Yoosoo Yang,et al.  Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. , 2017, Biomaterials.

[11]  C. Metzner,et al.  Biomedical applications of glycosylphosphatidylinositol-anchored proteins , 2016, Journal of Lipid Research.

[12]  M. Vallet‐Regí,et al.  Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues. , 2015, ACS applied materials & interfaces.

[13]  G. Hostetter,et al.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. , 2011, Cancer discovery.

[14]  H. Shepard,et al.  Effective targeting of the tumor microenvironment for cancer therapy. , 2012, Anticancer research.

[15]  Lily Yang,et al.  Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth. , 2016, Biomaterials.

[16]  Carolyn R. Bertozzi,et al.  The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins† , 2008, Biochemistry.

[17]  A. Molinari,et al.  Immune Surveillance Properties of Human NK Cell-Derived Exosomes , 2012, The Journal of Immunology.

[18]  G. Mazzolini,et al.  Altered hyaluronan biosynthesis and cancer progression: an immunological perspective. , 2009, Mini reviews in medicinal chemistry.

[19]  H. Shepard,et al.  Therapeutic Targeting of Hyaluronan in the Tumor Stroma , 2012, Cancers.

[20]  P. Zucca,et al.  Inorganic Materials as Supports for Covalent Enzyme Immobilization: Methods and Mechanisms , 2014, Molecules.

[21]  F. Szoka,et al.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[22]  R. Holcombe,et al.  Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer , 2016, Clinical Cancer Research.

[23]  M. Tammi,et al.  Hyaluronan-dependent pericellular matrix. , 2007, Advanced drug delivery reviews.

[24]  C. Wechselberger,et al.  In vitro mutagenesis of PH-20 hyaluronidase from human sperm. , 1997, European journal of biochemistry.

[25]  P. O'Connor,et al.  Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models , 2010, Molecular Cancer Therapeutics.

[26]  Hao Cheng,et al.  A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles , 2016, Theranostics.

[27]  Charles R. Martin.  Nanomedicine: a great first year and, with your help, a bright future ahead , 2007 .

[28]  H. Scrable,et al.  Isolation and Proteomic Analysis of Mouse Sperm Detergent-Resistant Membrane Fractions: Evidence for Dissociation of Lipid Rafts During Capacitation1 , 2005, Biology of reproduction.

[29]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[30]  Carla Oliveira,et al.  Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. , 2016, ACS nano.

[31]  A. I. Yudin,et al.  The PH-20 protein in human spermatozoa. , 1997, Journal of andrology.

[32]  S. Pun,et al.  Increased nanoparticle penetration in collagenase-treated multicellular spheroids , 2007, International journal of nanomedicine.

[33]  Juliane Nguyen,et al.  Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[35]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[36]  W. Grizzle,et al.  Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.

[37]  Dai Fukumura,et al.  Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.

[38]  H. Reyburn,et al.  A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008. , 2013, The Biochemical journal.

[39]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[40]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[41]  K. Kimata,et al.  Impact of the hyaluronan‐rich tumor microenvironment on cancer initiation and progression , 2008, Cancer science.

[42]  Rong Tong,et al.  New Strategies in Cancer Nanomedicine. , 2016, Annual review of pharmacology and toxicology.

[43]  G. Hunnicutt,et al.  Structural relationship of sperm soluble hyaluronidase to the sperm membrane protein PH-20. , 1996, Biology of reproduction.

[44]  Xin Hou,et al.  Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.

[45]  H. Duan,et al.  From structures to functions: insights into exosomes as promising drug delivery vehicles. , 2016, Biomaterials science.

[46]  Derek S. Chan,et al.  Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.

[47]  I. Kwon,et al.  Complex adaptive therapeutic strategy (CATS) for cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Linqiu Cao,et al.  Enzyme immobilisation: fundamentals and application. , 2013, Chemical Society reviews.

[49]  B. Toole,et al.  Hyaluronan: from extracellular glue to pericellular cue , 2004, Nature Reviews Cancer.

[50]  G. Kondoh,et al.  Mouse sperm undergo GPI-anchored protein release associated with lipid raft reorganization and acrosome reaction to acquire fertility , 2011, Journal of Cell Science.

[51]  G. Raposo,et al.  Lipid raft-associated protein sorting in exosomes. , 2003, Blood.

[52]  C. M. Roth,et al.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. , 2012, Critical reviews in biomedical engineering.

[53]  C. Tate.  Practical considerations of membrane protein instability during purification and crystallisation. , 2010, Methods in molecular biology.

[54]  Michelle E. Hung,et al.  Stabilization of Exosome-targeting Peptides via Engineered Glycosylation* , 2015, The Journal of Biological Chemistry.